These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5037033)

  • 21. Does prolonged pretreatment with large doses of spironolactone hasten a recovery from juxtaglomerular-adrenal suppression in primary aldosteronism?
    Morimoto S; Takeda R; Murakami M
    J Clin Endocrinol Metab; 1970 Dec; 31(6):659-64. PubMed ID: 4921649
    [No Abstract]   [Full Text] [Related]  

  • 22. Atrial fibrillation associated with hypokalemia due to primary hyperaldosteronism (Conn's syndrome).
    Al-Aloul B; Li JM; Benditt D; Tholakanahalli V
    Pacing Clin Electrophysiol; 2006 Nov; 29(11):1303-5. PubMed ID: 17100688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High doses of spironolactone (Aldactone, SC-14266, Verospirone) alone and in combination with triamterene and-or diuretics in the treatment of refractory edema associated with secondary hyperaldosteronism.
    Radó JP; Marosi J; Takó J
    Endokrinologie; 1970; 57(1):46-62. PubMed ID: 4923990
    [No Abstract]   [Full Text] [Related]  

  • 24. [Modern pharmacological aspects of hyperaldosteronism therapy].
    Quinkler M; Reincke M
    Internist (Berl); 2006 Sep; 47(9):953-9. PubMed ID: 16823578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conn's syndrome presenting as depression.
    Khurshid KA; Weaver ME
    Am J Psychiatry; 2005 Jun; 162(6):1226. PubMed ID: 15930081
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical experience in the use of Osyrol 100 and Osyrol for injection (author's transl)].
    Gorbach HC; Bräuninger HJ
    MMW Munch Med Wochenschr; 1975 Sep; 117(37):1483-6. PubMed ID: 810673
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.
    Karagiannis A; Tziomalos K; Papageorgiou A; Kakafika AI; Pagourelias ED; Anagnostis P; Athyros VG; Mikhailidis DP
    Expert Opin Pharmacother; 2008 Mar; 9(4):509-15. PubMed ID: 18312153
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [APROPOS OF A CASE OF CONN'S SYNDROME. THE DIFFERENTIAL DIAGNOSIS OF HYPERALDOSTERONISM WITH THE HELP OF DYNAMIC FUNCTION TESTS].
    DUPASQUIER E
    Helv Med Acta; 1964 Nov; 31():426-31. PubMed ID: 14335446
    [No Abstract]   [Full Text] [Related]  

  • 30. Renal calculi in primary hyperaldosteronism.
    Kabadi UM
    J Postgrad Med; 1995; 41(1):17-8. PubMed ID: 10740696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Severe hypokalemic myopathy as presentation form of primary aldosteronism].
    Paja M; Estrada FJ; Blanco C; Lucas T
    Med Clin (Barc); 1992 Jul; 99(6):234. PubMed ID: 1507916
    [No Abstract]   [Full Text] [Related]  

  • 32. Association between Crohn's disease and Conn's syndrome. A report of two cases.
    Astegiano M; Bresso F; Demarchi B; Sapone N; Novero D; Palestro G; Resegotti A; Pellicano R; Rizzetto M
    Panminerva Med; 2005 Mar; 47(1):61-4. PubMed ID: 15985978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary aldosteronism due to adrenocortical adenoma (Conn's syndrome).
    Stein L; Shapiro N; Stein D
    S Afr Med J; 1966 Nov; 40(41):993-6. PubMed ID: 5955092
    [No Abstract]   [Full Text] [Related]  

  • 34. Primary aldosteronism: the most frequent form of secondary hypertension?
    Shargorodsky M; Zimlichman R
    Isr Med Assoc J; 2002 Jan; 4(1):32-3. PubMed ID: 11802308
    [No Abstract]   [Full Text] [Related]  

  • 35. Modification of the effects of aldosterone on electrolyte excretion in man by simultaneous administration of corticosterone and hydrocortisone. Relevance to Conn's syndrome.
    ROSS EJ
    J Clin Endocrinol Metab; 1960 Feb; 20():229-37. PubMed ID: 13854575
    [No Abstract]   [Full Text] [Related]  

  • 36. Rhabdomyolysis due to primary hyperaldosteronism.
    Martínez JJ; Oliveira CL; Meneses AL; Rodríguez SA; Corrales PP; López AH; Romero FB
    Endocrinol Nutr; 2009 Oct; 56(8):431-4. PubMed ID: 19959155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The value of studying essential arterial hypertension with isotopic methods. Their application in arterial hypertension with low renin level].
    Olmer M; Salvadori JM; Paulin R; Sommer A; Marion J
    Nouv Presse Med; 1974 Feb; 3(5):233-6. PubMed ID: 4819942
    [No Abstract]   [Full Text] [Related]  

  • 38. Hyperaldosteronism after heart surgery in children. Part I: Treatment with aldosterone antagonists.
    Haschke F; Wimmer M; Parth K
    Padiatr Padol; 1981; 16(3):317-26. PubMed ID: 7254888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myopathy and primary hyperaldosteronism.
    Schady W; Yuill GM
    Neurology; 1981 Feb; 31(2):225-6. PubMed ID: 7193311
    [No Abstract]   [Full Text] [Related]  

  • 40. [Treatment of essential arterial hypertension with spironolactone: its value in the detection of primary hyperaldosteronism and prediction of its efficacy].
    Fournier A; Nakache JP; Salmon D; Kazandjian M; Baulon A; Legrand JC; Menard J; Lagrue G
    J Urol Nephrol (Paris); 1972 Dec; 78(12):1023-7. PubMed ID: 4661188
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.